AU Wells, AD King, MB Rubens, D Cramer, RM du Bois and DM Hansell
Department of Radiology, Royal Brompton Hospital London, United Kingdom.

In most clinical series of patients with cryptogenic fibrosing alveolitis (CFA), disease severity is staged using lung function indices. However, many physiologic indices are measured in routine clinical practice; the choice of variable to evaluate functional severity is contentious. Computed tomography (CT) provides a reproducible means of quantifying the morphologic extent of disease. The aim of this study was to evaluate the functional consequences of smoking-related lung damage in CFA and to identify functional measures best reflecting the extent of fibrosing alveolitis on CT. Sixty-eight patients with CFA were studied. Fourteen patients with emphysema on CT were characterized by relative preservation of FVC and TLC (p < 0.005) and relative depression of DLCO (p < 0.05) and KCO (p < 0.00005). On multivariate analysis, the extent of fibrosing alveolitis and the presence of emphysema were independent determinants of functional impairment; there was no independent relationship between smoking history and functional abnormalities. In patients without emphysema on CT, percent predicted DLCO (r = -0.68), oxygen desaturation on exercise (r = 0.64), and the physiologic component of the clinical-radiographic- physiologic (CRP) score (r = 0.62) correlated much better with the extent of disease on CT than spirometric and plethysmographic volumes. A composite functional index was generated against the extent of disease on CT, using multivariate analysis; comparison with the CRP score suggested that the relationship between morphologic disease extent and the CRP score would be improved by the inclusion of DLCO and by the use of negative weighting for depression of FEV1. These findings indicate that in CFA, the presence of concurrent emphysema on CT has a more profound influence upon functional measures than the smoking history, and underline the importance of both the measurements of DLCO and exercise testing in the assessment of the severity of CFA.

This article has been cited by other articles:

				K. M. Antoniou, D. M. Hansell, M. B. Rubens, K. Marten, S. R. Desai, N. M. Siafakas, A. G. Nicholson, R. M. du Bois, and A. U. Wells Idiopathic Pulmonary Fibrosis: Outcome in Relation to Smoking Status Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 190 - 194. [Abstract] [Full Text] [PDF]

				A. U Wells, A. G Nicholson, and D. M Hansell Challenges in pulmonary fibrosis {middle dot} 4: Smoking-induced diffuse interstitial lung diseases Thorax, October 1, 2007; 62(10): 904 - 910. [Abstract] [Full Text] [PDF]

				S. J. Copley, Y. C. G. Lee, D. M. Hansell, P. Sivakumaran, M. B. Rubens, A. J. Newman Taylor, R. M. Rudd, A. W. Musk, and A. U. Wells Asbestos-induced and Smoking-related Disease: Apportioning Pulmonary Function Deficit by Using Thin-Section CT Radiology, December 1, 2006; 242(1): 258 - 266. [Abstract] [Full Text] [PDF]

				K. P. Sylvester, S. R. Desai, A. U. Wells, D. M. Hansell, M. Awogbade, S. L. Thein, and A. Greenough Computed tomography and pulmonary function abnormalities in sickle cell disease Eur. Respir. J., October 1, 2006; 28(4): 832 - 838. [Abstract] [Full Text] [PDF]

				K. M. Antoniou, A. G. Nicholson, M. Dimadi, K. Malagari, P. Latsi, A. Rapti, N. Tzanakis, R. Trigidou, V. Polychronopoulos, and D. Bouros Long-term clinical effects of interferon gamma-1b and colchicine in idiopathic pulmonary fibrosis Eur. Respir. J., September 1, 2006; 28(3): 496 - 504. [Abstract] [Full Text] [PDF]

				F. J. Martinez and K. Flaherty Pulmonary function testing in idiopathic interstitial pneumonias. Proceedings of the ATS, January 1, 2006; 3(4): 315 - 321. [Abstract] [Full Text] [PDF]

				V. Cottin, H. Nunes, P-Y. Brillet, P. Delaval, G. Devouassoux, I. Tillie-Leblond, D. Israel-Biet, I. Court-Fortune, D. Valeyre, J-F. Cordier, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity Eur. Respir. J., October 1, 2005; 26(4): 586 - 593. [Abstract] [Full Text] [PDF]

				T. Eaton, P. Young, D. Milne, and A. U. Wells Six-Minute Walk, Maximal Exercise Tests: Reproducibility in Fibrotic Interstitial Pneumonia Am. J. Respir. Crit. Care Med., May 15, 2005; 171(10): 1150 - 1157. [Abstract] [Full Text] [PDF]

				T. S. Hallstrand, L. J. Boitano, W. C. Johnson, C. A. Spada, J. G. Hayes, and G. Raghu The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis Eur. Respir. J., January 1, 2005; 25(1): 96 - 103. [Abstract] [Full Text] [PDF]

				H. Monaghan, A. U. Wells, T. V. Colby, R. M. du Bois, D. M. Hansell, and A. G. Nicholson Prognostic Implications of Histologic Patterns in Multiple Surgical Lung Biopsies From Patients With Idiopathic Interstitial Pneumonias Chest, February 1, 2004; 125(2): 522 - 526. [Abstract] [Full Text] [PDF]

				V. N. Lama, K. R. Flaherty, G. B. Toews, T. V. Colby, W. D. Travis, Q. Long, S. Murray, E. A. Kazerooni, B. H. Gross, J. P. Lynch III, et al. Prognostic Value of Desaturation during a 6-Minute Walk Test in Idiopathic Interstitial Pneumonia Am. J. Respir. Crit. Care Med., November 1, 2003; 168(9): 1084 - 1090. [Abstract] [Full Text] [PDF]

				P. I. Latsi, R. M. du Bois, A. G. Nicholson, T. V. Colby, D. Bisirtzoglou, A. Nikolakopoulou, S. Veeraraghavan, D. M. Hansell, and A. U. Wells Fibrotic Idiopathic Interstitial Pneumonia: The Prognostic Value of Longitudinal Functional Trends Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 531 - 537. [Abstract] [Full Text] [PDF]

				D D Smith, Y C G. Lee, B Singh, S C Pang, N H de Klerk, D R Hillman, and A W Musk Earlier study on asbestos workers, ILO scores, and oxygenation more comprehensive * Authors' reply Occup. Environ. Med., August 1, 2003; 60(8): 611 - 611. [Full Text] [PDF]

				P. Kumar, P. Goldstraw, K. Yamada, A. G. Nicholson, A. U. Wells, D. M. Hansell, R. M. duBois, and G. Ladas Pulmonary fibrosis and lung cancer: Risk and benefit analysis of pulmonary resection J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1321 - 1327. [Abstract] [Full Text]

				A. U. Wells, S. R. Desai, M. B. Rubens, N. S. L. Goh, D. Cramer, A. G. Nicholson, T. V. Colby, R. M. du Bois, and D. M. Hansell Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 962 - 969. [Abstract] [Full Text] [PDF]

				Y C G Lee, B Singh, S C Pang, N H de Klerk, D R Hillman, and A W Musk Radiographic (ILO) readings predict arterial oxygen desaturation during exercise in subjects with asbestosis Occup. Environ. Med., March 1, 2003; 60(3): 201 - 206. [Abstract] [Full Text] [PDF]

				A. G. Nicholson, L. G. Fulford, T. V. Colby, R. M. du Bois, D. M. Hansell, and A. U. Wells The Relationship between Individual Histologic Features and Disease Progression in Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., July 15, 2002; 166(2): 173 - 177. [Abstract] [Full Text] [PDF]

				T. J. Gross and G. W. Hunninghake Idiopathic Pulmonary Fibrosis N. Engl. J. Med., August 16, 2001; 345(7): 517 - 525. [Full Text] [PDF]

				R.M. du Bois and A.U. Wells Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Eur. Respir. J., July 1, 2001; 18(32_suppl): 43S - 55s. [Abstract] [Full Text] [PDF]

				S. J. Copley, A. U. Wells, M. B. Rubens, F. Chabat, R. E. Sheehan, A. W. Musk, and D. M. Hansell Functional Consequences of Pleural Disease Evaluated with Chest Radiography and CT Radiology, July 1, 2001; 220(1): 237 - 243. [Abstract] [Full Text] [PDF]

				H R Roberts, A U Wells, D G Milne, M B Rubens, J Kolbe, P J Cole, and D M Hansell Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests Thorax, March 1, 2000; 55(3): 198 - 204. [Abstract] [Full Text]

				A. Wells Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis Thorax, December 1, 1998; 53(12): 1080 - 1087. [Full Text]

				A. XAUBET, C. AGUSTI, P. LUBURICH, J. ROCA, C. MONTON, M. C. AYUSO, J. A. BARBERA, and R. RODRIGUEZ-ROISIN Pulmonary Function Tests and CT Scan in the Management of Idiopathic Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 431 - 436. [Abstract] [Full Text] [PDF]